| 产品名称： | Candida albicans (Robin) Berkhout |
|---|---|
| 商品货号： | TS186802 |
| Deposited As： | Candida albicans (Robin) Berkhout, anamorph |
| Strain Designations： | RV 4688 |
| Application： | sterol synthesis and control with ketoconazole host-invader interplay |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | experimental infection in mice and guinea pigs attenuated ultrastructure after treatment with miconazole sterol synthesis and control with ketoconazole host-invader interplay azole-sensitive |
| Medium： | ATCC® Medium 200: YM agar or YM broth |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | J Van Cutsem |
| Chain of Custody： | ATCC < |
| Isolation： | human, Belgium |
| Cross References： | Nucleotide (GenBank) : AF153844 Candida albicans strain TS186802 cytochrome P450 lanosterol |
| References： | Van den Bossche H, et al. In vitro an in vivo effects of the antimycotic drug ketoconazole on sterol synthesis. Antimicrob. Agents Chemother. 17: 922-928, 1980. PubMed: 6250469 Banner W Jr., et al. Pharmacokinetics of nafcillin in infants with low birth weights. Antimicrob. Agents Chemother. 17: 691-694, 1980. PubMed: 7396459 De Nollin S, Borgers M. The ultrastructure of Candida albicans after in vitro treatment with miconazole. Sabouraudia 12: 341-351, 1974. PubMed: 4610826 Odds FC, et al. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host. Microbiology 146: 1881-1889, 2000. PubMed: 10931892 Smith KJ, et al. Azole resistance in Candida albicans. J. Med. Vet. Mycol. 24: 133-144, 1986. PubMed: 3014106 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Candida albicans (Robin) Berkhout |
|---|---|
| 商品货号： | TS186802 |
| Deposited As： | Candida albicans (Robin) Berkhout, anamorph |
| Strain Designations： | RV 4688 |
| Application： | sterol synthesis and control with ketoconazole host-invader interplay |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | experimental infection in mice and guinea pigs attenuated ultrastructure after treatment with miconazole sterol synthesis and control with ketoconazole host-invader interplay azole-sensitive |
| Medium： | ATCC® Medium 200: YM agar or YM broth |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | J Van Cutsem |
| Chain of Custody： | ATCC < |
| Isolation： | human, Belgium |
| Cross References： | Nucleotide (GenBank) : AF153844 Candida albicans strain TS186802 cytochrome P450 lanosterol |
| References： | Van den Bossche H, et al. In vitro an in vivo effects of the antimycotic drug ketoconazole on sterol synthesis. Antimicrob. Agents Chemother. 17: 922-928, 1980. PubMed: 6250469 Banner W Jr., et al. Pharmacokinetics of nafcillin in infants with low birth weights. Antimicrob. Agents Chemother. 17: 691-694, 1980. PubMed: 7396459 De Nollin S, Borgers M. The ultrastructure of Candida albicans after in vitro treatment with miconazole. Sabouraudia 12: 341-351, 1974. PubMed: 4610826 Odds FC, et al. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host. Microbiology 146: 1881-1889, 2000. PubMed: 10931892 Smith KJ, et al. Azole resistance in Candida albicans. J. Med. Vet. Mycol. 24: 133-144, 1986. PubMed: 3014106 |
